Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
Bridgewater J, Fletcher P, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans TR, Stocken D, Stubbs C, Praseedom R, Ma YT, Davidson B, Neoptolemos J, Iveson T, Cunningham D, Garden OJ, Valle JW, Primrose J; BILCAP study group. Bridgewater J, et al. Among authors: stubbs c. J Clin Oncol. 2022 Jun 20;40(18):2048-2057. doi: 10.1200/JCO.21.02568. Epub 2022 Mar 22. J Clin Oncol. 2022. PMID: 35316080 Clinical Trial.
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
Meyer T, Fox R, Ma YT, Ross PJ, James MW, Sturgess R, Stubbs C, Stocken DD, Wall L, Watkinson A, Hacking N, Evans TRJ, Collins P, Hubner RA, Cunningham D, Primrose JN, Johnson PJ, Palmer DH. Meyer T, et al. Among authors: stubbs c. Lancet Gastroenterol Hepatol. 2017 Aug;2(8):565-575. doi: 10.1016/S2468-1253(17)30156-5. Epub 2017 Jun 23. Lancet Gastroenterol Hepatol. 2017. PMID: 28648803 Free article. Clinical Trial.
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.
Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group. Primrose JN, et al. Among authors: stubbs c. Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Lancet Oncol. 2019. PMID: 30922733 Free article. Clinical Trial.
A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial.
Zarkar A, Pirrie S, Stubbs C, Hodgkins AM, Farrugia D, Fife K, MacDonald-Smith C, Vasudev N, Porfiri E; Pazo2 Investigators. Zarkar A, et al. Among authors: stubbs c. Clin Genitourin Cancer. 2022 Oct;20(5):473-481. doi: 10.1016/j.clgc.2022.06.012. Epub 2022 Jun 14. Clin Genitourin Cancer. 2022. PMID: 35803859 Free article. Clinical Trial.
A randomized trial of synthetic osmotic cervical dilator for induction of labor vs dinoprostone vaginal insert.
Gupta JK, Maher A, Stubbs C, Brocklehurst P, Daniels JP, Hardy P; Synthetic Osmotic Cervical Dilator for Induction of Labor in Comparison to Dinoprostone Vaginal insErt (SOLVE) collaborative group. Gupta JK, et al. Among authors: stubbs c. Am J Obstet Gynecol MFM. 2022 Jul;4(4):100628. doi: 10.1016/j.ajogmf.2022.100628. Epub 2022 Mar 28. Am J Obstet Gynecol MFM. 2022. PMID: 35358740 Free article. Clinical Trial.
Corrigendum to A randomized trial of synthetic osmotic cervical dilator for induction of labor vs dinoprostone vaginal insert American Journal of Obstetrics & Gynecology MFM Volume 4, Issue 4, July 2022, 100628.
Gupta JK, Maher A, Stubbs C, Brocklehurst P, Daniels JP, Hardy P; Synthetic Osmotic Cervical Dilator for Induction of Labor in Comparison to Dinoprostone Vaginal insErt (SOLVE) collaborative group. Gupta JK, et al. Among authors: stubbs c. Am J Obstet Gynecol MFM. 2022 Nov;4(6):100702. doi: 10.1016/j.ajogmf.2022.100702. Epub 2022 Aug 10. Am J Obstet Gynecol MFM. 2022. PMID: 35961850 Free article. No abstract available.
WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial - adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic.
Magee LA, Tohill S, Kirkham K, Evans R, Gkini E, Moakes CA, Stubbs C, Thornton J, von Dadelszen P; WILL Trial Study Group. Magee LA, et al. Among authors: stubbs c. Trials. 2022 Oct 21;23(1):884. doi: 10.1186/s13063-022-06834-4. Trials. 2022. PMID: 36271441 Free PMC article. Clinical Trial.
245 results